These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 2190286

  • 1. Are glomerular hypertension and "hypertrophy" independent risk factors for progression of renal disease?
    Lafferty HM, Brenner BM.
    Semin Nephrol; 1990 May; 10(3):294-304. PubMed ID: 2190286
    [No Abstract] [Full Text] [Related]

  • 2. Angiotensin-converting enzyme inhibitors in chronic renal failure.
    Opsahl JA, Abraham PA, Keane WF.
    Drugs; 1990 May; 39 Suppl 2():23-32. PubMed ID: 2188823
    [Abstract] [Full Text] [Related]

  • 3. Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.
    Guidi E, Minetti EE, Cozzi MG.
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):40-5. PubMed ID: 11984747
    [Abstract] [Full Text] [Related]

  • 4. [ACE inhibitors and the kidney].
    Hörl WH.
    Wien Med Wochenschr; 1996 Mar; 146(11):231-4; discussion 234-5. PubMed ID: 8928521
    [Abstract] [Full Text] [Related]

  • 5. [Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
    Barnas U, Mayer G.
    Wien Klin Wochenschr; 1995 Mar; 107(1):10-4. PubMed ID: 7871784
    [Abstract] [Full Text] [Related]

  • 6. Hypertensive nephrosclerosis.
    Luke RG.
    Kidney Int; 2006 Oct; 70(7):1383; author reply 1383-4. PubMed ID: 16988752
    [No Abstract] [Full Text] [Related]

  • 7. [Prevention of hypertensive nephropathy: what more besides arterial blood pressure control?].
    Francischetti EA.
    Arq Bras Cardiol; 1992 Apr; 58(4):325-36. PubMed ID: 1340704
    [No Abstract] [Full Text] [Related]

  • 8. [Does intraglomerular hypertension determine the progression of chronic renal failure?].
    Grünfeld JP.
    Rev Prat; 1989 Jun 01; 39(17):1510-3. PubMed ID: 2740798
    [No Abstract] [Full Text] [Related]

  • 9. Glomerular hypertrophy accelerates hypertensive glomerular injury in rats.
    Miller PL, Rennke HG, Meyer TW.
    Am J Physiol; 1991 Sep 01; 261(3 Pt 2):F459-65. PubMed ID: 1887907
    [Abstract] [Full Text] [Related]

  • 10. Hyperfiltration-mediated Injury in the Remaining Kidney of a Transplant Donor.
    Srivastava T, Hariharan S, Alon US, McCarthy ET, Sharma R, El-Meanawy A, Savin VJ, Sharma M.
    Transplantation; 2018 Oct 01; 102(10):1624-1635. PubMed ID: 29847501
    [Abstract] [Full Text] [Related]

  • 11. The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection: frustration and promises.
    Schieppati A, Remuzzi G.
    Kidney Int; 2003 Dec 01; 64(6):1947-55. PubMed ID: 14633117
    [No Abstract] [Full Text] [Related]

  • 12. Hyperfiltration and diabetic nephropathy: is it the beginning? Or is it the end?
    Castellino P, Shohat J, DeFronzo RA.
    Semin Nephrol; 1990 May 01; 10(3):228-41. PubMed ID: 2190280
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin converting enzyme inhibitors and progression of chronic renal failure.
    Tolins JP, Raij L.
    Kidney Int Suppl; 1990 Nov 01; 30():S118-22. PubMed ID: 2259070
    [Abstract] [Full Text] [Related]

  • 14. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.
    Clin Nephrol; 2001 May 01; 55(5):375-83. PubMed ID: 11393383
    [Abstract] [Full Text] [Related]

  • 15. [Mechanisms of progression of glomerular sclerosis in chronic renal diseases in man].
    Garini G, Allegri L, Arisi L.
    Ann Ital Med Int; 1989 May 01; 4(3):184-94. PubMed ID: 2702030
    [Abstract] [Full Text] [Related]

  • 16. Impact of calcium entry blockers on glomerular injury in experimental hypertension.
    Dworkin LD.
    Cardiovasc Drugs Ther; 1990 Oct 01; 4(5):1325-30. PubMed ID: 2278867
    [Abstract] [Full Text] [Related]

  • 17. Effects of different converting-enzyme inhibitors on the course of non-diabetic glomerulopathies.
    Bernheim J.
    Nephrol Dial Transplant; 1990 Oct 01; 5(10):837-40. PubMed ID: 2128376
    [No Abstract] [Full Text] [Related]

  • 18. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G.
    J Nephrol; 2012 Oct 01; 25(5):810-8. PubMed ID: 22252844
    [Abstract] [Full Text] [Related]

  • 19. [Kidney and arterial hypertension].
    Maxwell MH.
    Presse Med (1893); 1969 May 28; 77(26):943-6. PubMed ID: 5795140
    [No Abstract] [Full Text] [Related]

  • 20. [Early renal hemodynamic modifications during diabetes mellitus: physiopathologic mechanisms].
    Hannedouche T, Boitard C, Delgado A, Gnionsahe A, Lazaro M, Assan R, Grünfeld JP.
    Journ Annu Diabetol Hotel Dieu; 1989 May 28; ():213-24. PubMed ID: 2668615
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.